News

Gastrointestinal mastocytosis occurs in about one-third of patients with systemic mastocytosis and strongly predicts bone marrow involvement.

A true diagnosis of mast cell diseases like SM requires specific clinical, biochemical and molecular criteria, researchers stress.

The treatment of bone disease associated with SM requires measures that target the mast cells that drive disease processes.

A CME intervention led to significant improvements in allergists’ knowledge and confidence in diagnosing and managing SM, study finds.

An unusual case of anaphylaxis following ackee fruit ingestion led to the unexpected diagnosis of indolent systemic mastocytosis (SM).

High-throughput proteomics and machine learning helped uncover new protein signatures with useful prognostic implications in SM.

Patients with indolent SM who took avapritinib saw significant improvements in itching, flushing and skin spots that lasted for three years.

A recent case report shows how inconclusive early testing led to a delayed diagnosis of indolent SM marked by chronic anaphylaxis.

Researchers found natural language processing could accurately identify symptoms of SM hidden in electronic medical records.

Individuals with mast cell diseases like SM may experience cardiac, vascular and bleeding symptoms that need specialized care.